Based on the findings, propofol post-treatment promotes cell survival through inhibiting apoptosis and autophagy induced by hypoxia/reoxygenation in H9c2 cells under hyperglycemia, and that activation of FoxO1 and FoxO3a expression is key for propofol to confer such cardiac protection. Here, FOXO3 is linked to Hyperglycemia.